FuturHealth vs NovoCare Pharmacy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
FuturHealth
Best for readers who want both brand-name and compounded GLP-1 options on one platform with registered-dietitian nutrition coaching, AND are willing to read the data-breach litigation disclosure before signing upStarting at $199/mo
NovoCare Pharmacy
Best for branded Wegovy at the lowest manufacturer-direct self-pay priceStarting at $199/mo
Side-by-Side Comparison
| Feature | FuturHealth | NovoCare Pharmacy |
|---|---|---|
| Overall Score | 6.7/10 | ✓8.7/10 |
| Starting Price | $199/mo | $199/mo |
| Editorial Rating | 3.4 ★ /5 | ✓4.4 ★ /5 |
| Features | ✓10 features | 5 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
FuturHealth
Pros
- ✓LegitScript Certified and HITRUST Certified — two independently verifiable telehealth/health-data trust marks
- ✓Brand-name injection + oral pill GLP-1s on one platform: Wegovy injection, Wegovy oral pill, Zepbound, Mounjaro, Ozempic, Foundayo (orforglipron oral, added Q2 2026), plus clinician-discretionary compounded options
- ✓First-mover on dispensing Foundayo (orforglipron, FDA-approved April 2026) — earliest direct-to-consumer access to the new oral non-peptide GLP-1
- ✓Bundled registered-dietitian nutrition guidance — most pure-Rx telehealths leave nutrition support to the patient
Cons
- ✗ACTIVE LITIGATION: Wilson v. FuturHealth Inc., U.S. District Court Southern District of California, Case No. 3:2025cv00157, alleging unauthorized access to G-Plans subscriber data on/before October 16, 2024 and asserting CCPA, medical-confidentiality, and negligence claims. Material disclosure for any reader signing up.
- ✗BBB complaint pattern: multiple consumer reports of recurring unauthorized charges (e.g. $396/month) without medication being received — verify cancellation flow before subscribing
- ✗Pharmacy partners are described as 'licensed, U.S.-based pharmacies' but no specific 503A/503B partners are publicly named
- ✗Pricing is not displayed on the public landing page — visible only after qualification questionnaire/portal login
- ✗Clinical platform is white-labeled on top of SteadyMD and OpenLoop infrastructure — FuturHealth is the front-end brand, not the first-party prescribing entity
NovoCare Pharmacy
Pros
- ✓First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
- ✓$199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
- ✓$349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
- ✓Ships to all 50 states; no telehealth-platform middleman fees
- ✓Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
- ✓Insurance-billing path also available via the standard NovoCare savings program
Cons
- ✗Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
- ✗Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
- ✗$199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
- ✗No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
- ✗Manufacturer-set pricing can change at any time
Our Verdict
NovoCare Pharmacy edges out FuturHealth with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. FuturHealth remains a solid alternative, especially if you're looking for readers who want both brand-name and compounded GLP-1 options on one platform with registered-dietitian nutrition coaching, AND are willing to read the data-breach litigation disclosure before signing up.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring FuturHealth and NovoCare Pharmacy head-to-heads in the same category.
- FuturHealth vs CoreAge Rx
- FuturHealth vs TrimRx
- FuturHealth vs Amazon One Medical
- NovoCare Pharmacy vs Vytora Health
- NovoCare Pharmacy vs Enhance MD
- NovoCare Pharmacy vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.